Cross-talk between immune system and microbiota in COVID-19

References

• Mathew S, Smatti MK, Al Ansari K, et al. Mixed viral-bacterial infections and their effects on gut microbiota and clinical illnesses in children. Sci Rep. 2019;9(1):865.
   PubMedGoogle Scholar
• Hanada S, Pirzadeh M, Carver KY, et al. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol. 2018;9:2640.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy. 2020;5:6.
   PubMedGoogle Scholar
• Cully M. Immune status could determine efficacy of COVID-19 therapies. Nat Rev Drug Discov. 2020;19(7):431–434.
   PubMed Web of Science ®Google Scholar
• Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95.
   PubMed Web of Science ®Google Scholar
• El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal complications in critically ill patients with and without COVID-19. JAMA. 2020;324(18):1899–901.
   PubMed Web of Science ®Google Scholar
• Kaafarani HM, El Moheb M, Hwabejire JO, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020;272(2):e61.
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DLA, et al. Emerging pathogenic links between microbiota and the gut–lung axis. Nature Rev Microbiol. 2017;15(1):55.
   PubMed Web of Science ®Google Scholar
• Hugon P, Dufour J-C, Colson P, et al. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis. 2015;15(10):1211–19.
   PubMed Web of Science ®Google Scholar
• Cianci R, Pagliari D, Piccirillo CA, et al. The microbiota and immune system crosstalk in health and disease. Mediators of Inflammation. 2018;2018:1–3.
   Web of Science ®Google Scholar
• Zhu G, Jiang Y, Yao Y, et al. Ovotransferrin ameliorates the dysbiosis of immunomodulatory function and intestinal microbiota induced by cyclophosphamide. Food Funct. 2019;10(2):1109–1122.
   PubMed Web of Science ®Google Scholar
• Xie Q, Pan M, Huang R, et al. Modulation of the small intestinal microbial community composition over short-term or long-term administration with Lactobacillus plantarum ZDY2013. J Dairy Sci. 2016;99(9):6913–21.
   PubMed Web of Science ®Google Scholar
• Belizário JE, Faintuch J. Microbiome and gut dysbiosis. Exp Suppl. 2018;109:459–476.
   PubMedGoogle Scholar
• Round JL, Mazmanian SKJNRI. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–23.
   PubMed Web of Science ®Google Scholar
• Kamada N, Seo S-U, Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321–35.
   PubMed Web of Science ®Google Scholar
• Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health. Nat Clin Pract Gastroenterol Hepatol. 2012;9(10):577.
   Google Scholar
• Mazmanian SK, Round JL, Kasper DLJN. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453(7195):620–5.
   PubMed Web of Science ®Google Scholar
• Gérard PJP. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens. 2014;3(1):14–24.
   Google Scholar
• Mezouar S, Chantran Y, Michel J, et al. Microbiome and the immune system: from a healthy steady-state to allergy associated disruption. Hum Microbiome J. 2018;10:11–20.
   Google Scholar
• Fleck A-K, Schuppan D, Wiendl H,et al. Gut–CNS-axis as possibility to modulate inflammatory disease activity—Implications for multiple sclerosis. Int J Mol Sci. 2017;18(7):1526.
   Web of Science ®Google Scholar
• Wiest R, Albillos A, and Trauner, M et al. Targeting the gut-liver axis in liver disease. J Hepatol . 2017;67(5):1084–1103.
   PubMed Web of Science ®Google Scholar
• Yurkovetskiy L, Burrows M, Khan A, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity. 2013;39(2):400–412.
   PubMed Web of Science ®Google Scholar
• Salem I, Ramser, A, and Isham, N, et al. The gut microbiome as a major regulator of the gut-skin axis Front Microbiol . 2018;9:1459.
   PubMed Web of Science ®Google Scholar
• Sencio V, Barthelemy A, Tavares LP, et al. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep. 2020;30(9):2934–2947.
   PubMed Web of Science ®Google Scholar
• Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65(4):575–83.
   PubMed Web of Science ®Google Scholar
• Keely S, Talley NJ, Hansbro PMJMI. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5(1):7–18.
   PubMed Web of Science ®Google Scholar
• Yazar A, Atis S, Konca K, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96(5):1511–1516.
   PubMed Web of Science ®Google Scholar
• Lotz MT, Peebles RS. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr Allergy Asthma Rep. 2012;12(5):380–387.
   PubMed Web of Science ®Google Scholar
• Brodin P, Davis MM. Human immune system variation. Nat Rev Immunol. 2017;17(1):21.
   PubMed Web of Science ®Google Scholar
• Odamaki T, Kato K, Sugahara H, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16(1):1–12.
   PubMed Web of Science ®Google Scholar
• Fouhy F, Ross RP, Fitzgerald GF, et al. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012;3(3):203–220.
   PubMed Web of Science ®Google Scholar
• Levine KM, Priedigkeit N, Basudan A, et al. FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. NPJ Breast Cancer. 2019;5(1):1–5.
   PubMedGoogle Scholar
• Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8:51.
   PubMed Web of Science ®Google Scholar
• Russell SL, Gold MJ, Reynolds LA, et al. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J Allergy Clin Immunol. 2015;135(1):100–9. e5.
   PubMed Web of Science ®Google Scholar
• Han Y, Jia, Z, and Shi, J, et al. The active lung microbiota landscape of COVID-19 patients. medRxiv, 2020.
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–1836.
   PubMed Web of Science ®Google Scholar
• Scarpellini E, Fagoonee S, Rinninella E, et al. Gut microbiota and liver interaction through immune system cross-talk: a comprehensive review at the time of the SARS-COV-2 pandemic. J Clin Med. 2020;9(8):2488.
   Web of Science ®Google Scholar
• Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.
   PubMed Web of Science ®Google Scholar
• Rabizadeh S, Rhee K-J, Wu S, et al. Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis. 2007;13(12):1475–1483.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–341.
   PubMed Web of Science ®Google Scholar
• Mukhopadhya I, Segal, JP, and Carding, SR, et al. The gut virome: the ‘missing link’between gut bacteria and host immunity? Therap Adv Gastroenterol. 2019;12:1756284819836620.
   Web of Science ®Google Scholar
• Scarpellini E, Ianiro G, Attili F, et al. The human gut microbiota and virome: potential therapeutic implications. Digestive Liver Dis. 2015;47(12):1007–1012.
   Web of Science ®Google Scholar
• Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492–506.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141.
   PubMed Web of Science ®Google Scholar
• Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84.
   PubMed Web of Science ®Google Scholar
• Owaga E, Hsieh R-H, Mugendi B, et al. Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases. Int J Mol Sci. 2015;16(9):20841–20858.
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455.
   PubMed Web of Science ®Google Scholar
• Cheng H-Y, Ning, MX, and Chen, DK, et al. Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol. 2019;10. DOI:https://doi.org/10.3389/fimmu.2019.00607.
   Google Scholar
• Pagliari D, Piccirillo CA, Larbi A, et al. The interactions between innate immunity and microbiota in gastrointestinal diseases. J Immunol Res. 2015;2015:1–3.
   Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–498.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–1273.
   PubMed Web of Science ®Google Scholar
• Gaudino SJ, Kumar P. Cross-Talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis. Front Immunol. 2019;10:360.
   PubMed Web of Science ®Google Scholar
• Bene K, Varga Z, Petrov VO, et al. Gut microbiota species can provoke both inflammatory and tolerogenic immune responses in human dendritic cells mediated by retinoic acid receptor alpha ligation. Front Immunol. 2017;8:427.
   PubMed Web of Science ®Google Scholar
• Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4–14.
   PubMed Web of Science ®Google Scholar
• Flannigan KL, Denning TL. Segmented filamentous bacteria‐induced immune responses: a balancing act between host protection and autoimmunity. Immunology. 2018;154(4):537–546.
   Web of Science ®Google Scholar
• Lécuyer E, Rakotobe S, Lengliné-Garnier H, et al. Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity. 2014;40(4):608–620.
   PubMed Web of Science ®Google Scholar
• Salzman NHJG. m., Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces. Gut Microbes. 2010;1(6):401–406.
   PubMed Web of Science ®Google Scholar
• Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31(4):677–689.
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41.
   PubMed Web of Science ®Google Scholar
• Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020;11:25.
   PubMed Web of Science ®Google Scholar
• Corrêa‐Oliveira R, Fachi JL, Vieira A, et al. Regulation of immune cell function by short‐chain fatty acids. Clin Transl Immunology. 2016;5(4):e73.
   PubMedGoogle Scholar
• Rosshart SP, Vassallo BG, Angeletti D, et al. Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell. 2017;171(5):1015–1028.
   PubMed Web of Science ®Google Scholar
• Khosravi A, Yáñez, A, and Price, JG, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe. 2014;15(3):374–381.
   PubMed Web of Science ®Google Scholar
• Lo BC, Shin, SB, and Canals Hernaez, D, et al. IL-22 preserves gut epithelial integrity and promotes disease remission during chronic Salmonella infection. J Immunol. 2019;202(3):956–965.
   PubMed Web of Science ®Google Scholar
• Chen GY, Liu, M, and Wang, F, et al. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol. 2011;186(12):7187–7194.
   PubMed Web of Science ®Google Scholar
• Lukasova M, Malaval, C, and Gille, A, et al. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Investig. 2011;121(3):1163–1173.
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282–1286.
   PubMed Web of Science ®Google Scholar
• Gustafsson JK, Ermund A, Johansson MEV, et al. An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am J Physiol Gastrointest Liver Physiol. 2012;302(4):G430–8.
   PubMed Web of Science ®Google Scholar
• Jung T-H, Park JH, Jeon W-M, et al. Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway. Nutr Res Pract. 2015;9(4):343–349.
   PubMed Web of Science ®Google Scholar
• Diamond G, Beckloff N, Weinberg A, et al. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des. 2009;15(21):2377–2392.
   PubMed Web of Science ®Google Scholar
• Kim D, Zeng MY, Núñez G, et al. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp Mol Med. 2017;49(5):e339.
   PubMed Web of Science ®Google Scholar
• Canani RB, Costanzo, MD, and Leone L, et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17(12):1519–1528.
   PubMed Web of Science ®Google Scholar
• Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775.
   PubMed Web of Science ®Google Scholar
• Jiminez JA, Uwiera, TC, and Abbott, DW, et al. Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal in flammation in mice infected with Citrobacter rodentium. MSphere. 2017;2(4);e00243–17.
   PubMed Web of Science ®Google Scholar
• Frieman M, Heise M, Baric RJVR. SARS coronavirus and innate immunity. Virus Res. 2008;133(1):101–12.
   PubMed Web of Science ®Google Scholar
• Yitbarek A, Taha-Abdelaziz, K, and Hodgins, DC, et al. Gut microbiota-mediated protection against influenza virus subtype H9N2 in chickens is associated with modulation of the innate responses. Sci Rep. 2018;8(1):1–12.
   PubMedGoogle Scholar
• Menendez A, Willing, BP, and Montero, M, et al. Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell α-defensins. J Innate Immun. 2013;5(1):39–49.
   PubMed Web of Science ®Google Scholar
• Cianci R, et al. Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. J Biol Regul Homeostat Agents. 2010;24(3):239
   PubMed Web of Science ®Google Scholar
• Francino MPJP. Early development of the gut microbiota and immune health. Pathogens. 2014;3(3):769–790.
   PubMedGoogle Scholar
• Arrazuria R, Pérez V, Molina E, et al. Diet induced changes in the microbiota and cell composition of rabbit gut associated lymphoid tissue (GALT). Sci Rep. 2018;8(1):14103.
   PubMedGoogle Scholar
• Ahluwalia B, Magnusson MK, Öhman L. Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Scand J Gastroenterol. 2017;52(11):1185–1193.
   PubMed Web of Science ®Google Scholar
• Fagarasan S, Muramatsu M, Suzuki K, et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science. 2002;298(5597):1424–1427.
   PubMed Web of Science ®Google Scholar
• Kasarello K, Sajdel-Sulkowska EM. Developmental significance of early gut-associated lymphoid tissue (GALT)-microbiota interactions in health and disease: creating balance between tolerance and inflammation in children. Open J Pediatr Child Health. 2019;4(1): 040–6. doi:https://doi.org/10.17352/ojpch.000019.
   Google Scholar
• Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1073–1080.
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Trompette A, Gollwitzer ESJAOTATS. The gut–lung axis in respiratory disease. Ann Am Thorac Soc. 2015;12(Supplement 2):S150–S156.
   PubMedGoogle Scholar
• Enaud R, Prevel R, Ciarlo E, et al. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020;10:9.
   PubMed Web of Science ®Google Scholar
• Dickson RP, Singer BH, Newstead MW, et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016;1(10):1–9.
   Web of Science ®Google Scholar
• Fanos V, Pintus, MC, and Pintus, R, et al. Lung microbiota in the acute respiratory disease: from coronavirus to metabolomics. J Pediatr Neonatal Individ Med(JPNIM). 2020;9(1): e090139
   Web of Science ®Google Scholar
• Battaglini D, Robba C, Fedele A, et al. The role of dysbiosis in critically ill patients with COVID-19 and acute respiratory distress syndrome. Front Med. 2021;8:826.
   Web of Science ®Google Scholar
• Looft T, Allen HKJGM. Collateral effects of antibiotics on mammalian gut microbiomes. Gut Microbes. 2012;3(5):463–467.
   PubMed Web of Science ®Google Scholar
• Fujimura KE, Lynch SVJCH. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17(5):592–602.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Marsland B, et al. The gut–liver–lung axis. Modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease. Am J Resp Cell Mol Biol. 2016;54(2):161–169.
   PubMed Web of Science ®Google Scholar
• Baradaran Ghavami SH, Sharokh, SH, and Hossein-Khannazer, N, et al. IBD patients could be silent carriers for novel coronavirus and less prone to its severe adverse events: true or false? Cell J. 2020;22(Suppl 1):151–4.
   PubMedGoogle Scholar
• Denny JE, Powell WL, Schmidt NW, et al. Local and long-distance calling: conversations between the gut microbiota and intra-and extra-gastrointestinal tract infections. Front Cell Infect Microbiol. 2016;6:41.
   PubMed Web of Science ®Google Scholar
• Coopersmith CM, Stromberg PE, Davis CG, et al. Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med. 2003;31(6):1630–1637.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Rajput S, Paliwal, D, and Naithani, M, et al. COVID-19 and gut microbiota: a potential connection. Indian J Clin Biochem. 2021;36(3) ;1–12.
   Web of Science ®Google Scholar
• Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol. 2018;9:2147.
   PubMed Web of Science ®Google Scholar
• Arrieta M-C, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152.
   PubMed Web of Science ®Google Scholar
• Lynch S, Sitarik, AR, and Havstad, S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation Nat Med . 2016;22(10):1187–1191 .
   PubMed Web of Science ®Google Scholar
• Demirci M, Tokman HB, Uysal HK, et al. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. Allergol Immunopathol (Madr). 2019;47(4):365–371.
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107(1):129–134.
   PubMed Web of Science ®Google Scholar
• Hilty M, Burke, C, and Pedro, H, et al. Disordered microbial communities in asthmatic airways. PloS One. 2010;5(1):e8578.
   PubMed Web of Science ®Google Scholar
• Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957–963.
   PubMed Web of Science ®Google Scholar
• Antosca KM, Chernikova DA, Price CE, et al. Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth. J Bacteriol. 2019;201(16):e00274–19.
   PubMed Web of Science ®Google Scholar
• Burke DG, Fouhy, F, and Harrison, MJ, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol. 2017;17(1):58.
   PubMedGoogle Scholar
• Fouhy F, Ronan NJ, O’Sullivan O, et al. A pilot study demonstrating the altered gut microbiota functionality in stable adults with cystic fibrosis. Sci Rep. 2017;7(1):1–12.
   PubMedGoogle Scholar
• Debyser G, Mesuere B, Clement L, et al. Faecal proteomics: a tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. J Cyst Fibros. 2016;15(2):242–250.
   PubMed Web of Science ®Google Scholar
• Blainey PC, Milla, CE, and Cornfield, DN, et al. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med. 2012;4(153):153ra130.
   PubMed Web of Science ®Google Scholar
• Kolak M, Karpati, F, and Monstein, H-J, et al. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients. Int J Med Microbiol. 2003;293(4):309–317.
   PubMed Web of Science ®Google Scholar
• Zhuang H, Cheng L, Wang Y, et al. Dysbiosis of the gut microbiome in lung cancer. Front Cell Infect Microbiol. 2019;9:112.
   PubMed Web of Science ®Google Scholar
• Rosas-Salazar C, Shilts MH, Tovchigrechko A, et al. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy. J Infect Dis. 2016;214(12):1924–8.
   PubMed Web of Science ®Google Scholar
• Hofstra JJ, Matamoros, S, and van de Pol, MA, et al. Changes in microbiota during experimental human Rhinovirus infection. BMC Infect Dis. 2015;15(1):1–9.
   PubMedGoogle Scholar
• Karppinen S, Teräsjärvi, J, and Auranen, K, et al. Acquisition and transmission of Streptococcus pneumoniae are facilitated during rhinovirus infection in families with children. Am J Respir Crit Care Med. 2017;196(9):1172–1180.
   PubMed Web of Science ®Google Scholar
• Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(10):1224–1231.
   PubMed Web of Science ®Google Scholar
• Allen EK, Koeppel, AF, and Hendley, JO, et al. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2014;2(1):22.
   PubMedGoogle Scholar
• Lu H-F, Li, A, and Zhang, T, et al. Disordered oropharyngeal microbial communities in H7N9 patients with or without secondary bacterial lung infection. Emerg Microbes Infect. 2017;6(1):1–11.
   PubMed Web of Science ®Google Scholar
• Leung R-K, Zhou J-W, Guan W, et al. Modulation of potential respiratory pathogens by pH1N1 viral infection. Clin Microbiol Infect. 2013;19(10):930–935.
   PubMed Web of Science ®Google Scholar
• Rogers GB, Shaw D, Marsh RL, et al. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax. 2015;70(1):74–81.
   PubMed Web of Science ®Google Scholar
• Qin N, Zheng, B, and Yao, J, et al. Influence of H7N9 virus infection and associated treatment on human gut microbiota. Sci Rep. 2015;5:14771.
   PubMed Web of Science ®Google Scholar
• Saitou M, Nemoto D, Utano K, et al. Identification of intestinal abnormalities in patients with active pulmonary tuberculosis using small bowel capsule endoscopy. Endosc Int Open. 2018;6(9):E1103.
   PubMed Web of Science ®Google Scholar
• Luo M, Liu Y, Wu P, et al. Alternation of gut microbiota in patients with pulmonary tuberculosis. Front Physiol. 2017;8:822.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li, S, and Wang, N, et al. The cross-talk between gut microbiota and lungs in common lung diseases. Front Microbiol. 2020;11: 301.
   PubMed Web of Science ®Google Scholar
• Neu U, Mainou BA, Evans MJ. Virus interactions with bacteria: partners in the infectious dance. PLoS Pathog. 2020;16(2):e1008234.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Balkhy H, Gabere MN. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review. J Infect Public Health. 2018;11(1):9–17.
   PubMed Web of Science ®Google Scholar
• Du L, He Y, Zhou Y, et al. The spike protein of SARS-CoV—a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226–236.
   PubMed Web of Science ®Google Scholar
• Zeppa SD, Agostini, D, and Piccoli, G, et al. Gut microbiota status in COVID-19: an unrecognized player? Front Cell Infect Microbiol. 2020;10 576551 .
   PubMed Web of Science ®Google Scholar
• Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci. 2011;108(13):5354–5359.
   PubMed Web of Science ®Google Scholar
• Abt MC, Osborne L, Monticelli L, et al. Commensal bacteria calibrate the activation threshold of innate antiviral. immunity. 2012;37(1):158–170.
   PubMed Web of Science ®Google Scholar
• Allie SR, Bradley JE, Mudunuru U, et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nat Immunol. 2019;20(1):97–108.
   PubMed Web of Science ®Google Scholar
• Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58–60.
   PubMed Web of Science ®Google Scholar
• Lv L, Gu S, Jiang H, et al. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features. Commun Biol. 2021;4(1):480.
   PubMed Web of Science ®Google Scholar
• Forbes JD, Bernstein CN, Tremlett H, et al. A fungal world: could the gut mycobiome be involved in neurological disease? Front Microbiol. 2019;9:3249.
   PubMed Web of Science ®Google Scholar
• Lv L, Gu, S, and Jiang, H, et al. Gut mycobiota alterations in patients with COVID-19 and H1N1 and their associations with clinical features Commun Biol . 2021;4(1): 480 .
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhang F, Lui GCY, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944–955. e8.
   PubMed Web of Science ®Google Scholar
• Gou W, Fu, Y, and Yue, L, et al., Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. MedRxiv, 2020.
   Google Scholar
• Zuo T, Liu, Q, and Zhang, F, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70(2):276–284.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shi X, Fu W, et al. Gut microbiota dysbiosis correlates with abnormal immune response in moderate COVID-19 patients with fever. J Inflamm Res. 2021;14:2619–2631.
   PubMed Web of Science ®Google Scholar
• Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020;71(10):2669–2678.
   PubMed Web of Science ®Google Scholar
• Yeoh YK, Zuo T, Lui GC-Y, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698–706.
   PubMed Web of Science ®Google Scholar
• Tang L, Gu S, Gong Y, et al. Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering. 2020;6(10):1178–1184.
   Web of Science ®Google Scholar
• Khatiwada S, Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): possible link and implications. Hum Microbiome J. 2020;17:100073.
   PubMedGoogle Scholar
• Kalina U, Koyama N, Hosoda T, et al. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region. Eur J Immunol. 2002;32(9):2635–2643.
   PubMed Web of Science ®Google Scholar
• Domínguez-Cherit G, Lapinsky, SE, and Macias, AE, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA. 2009;302(17):1880–1887.
   PubMed Web of Science ®Google Scholar
• Yasui H, Kiyoshima J, Hori TJCDLI. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Vaccin Immunol. 2004;11(4):675–679.
   Google Scholar
• Tomosada Y, Chiba E, Zelaya H, et al. Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection. BMC Immunol. 2013;14(1):40.
   PubMedGoogle Scholar
• Mailliard RB, Son Y-I, Redlinger R, et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol. 2003;171(5):2366–2373.
   PubMed Web of Science ®Google Scholar
• Kitazawa H, Villena JJFII. Modulation of respiratory TLR3-anti-viral response by probiotic microorganisms: lessons learned from Lactobacillus rhamnosus CRL1505. Front Immunol. 2014;5:201.
   PubMed Web of Science ®Google Scholar
• Yilla M, Harcourt BH, Hickman CJ, et al. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res. 2005;107(1):93–101.
   PubMed Web of Science ®Google Scholar
• Cinatl J Jr., Hoever G, Morgenstern B, et al. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol Life Sci. 2004;61(16):2100–12.
   PubMed Web of Science ®Google Scholar
• Spiegel M, Schneider K, Weber F, et al. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol. 2006;87(7):1953–60.
   PubMedGoogle Scholar
• Simmons G, Gosalia DN, Rennekamp AJ, et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A. 2005;102(33):11876–11881.
   PubMed Web of Science ®Google Scholar
• Fischer DD, Kandasamy S, Paim FC, et al. Protein malnutrition alters tryptophan and angiotensin-converting enzyme 2 homeostasis and adaptive immune responses in human rotavirus-infected gnotobiotic pigs with human infant fecal microbiota transplant. Clin Vaccin Immunol. 2017;24(8):e00172–17.
   PubMedGoogle Scholar
• Vighi G, Marcucci F, Sensi L, et al. Allergy and the gastrointestinal system. Clin Exp Immunol. 2008;153(Suppl 1):3–6.
   PubMedGoogle Scholar
• Mikelsaar M, Lazar V, Onderdonk A, et al. Do probiotic preparations for humans really have efficacy? Microb Ecol Health Dis. 2011;22(1):10128.
   Web of Science ®Google Scholar
• Kong YH, Shi, Q, and Han, N, et al. Structural modulation of gut microbiota in rats with allergic bronchial asthma treated with recuperating lung decoction. Biomed Environ Sci. 2016;29(8):574–583.
   PubMed Web of Science ®Google Scholar
• Villena J, Salva S, Barbieri N, et al. Immunobiotics for the Prevention of Bacterial and Viral Respiratory Infections Probiotics 1. Boca Raton: CRC Press. 2013:128–168. 9780429090684 .
   Google Scholar
• Mullish BH, Marchesi JR, McDonald JAK, et al. Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics? Gut Microbes. 2021;13(1):1900997.
   Web of Science ®Google Scholar
• Bron PA, Kleerebezem M, Brummer R-J, et al. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr. 2017;117(1):93–107.
   PubMed Web of Science ®Google Scholar
• Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92.
   PubMed Web of Science ®Google Scholar
• Olaimat AN, Aolymat I, Al-Holy M, et al. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Science Food. 2020;4(1):1–7.
   PubMedGoogle Scholar
• Fujiwara S, Seto Y, Kimura A, et al. Establishment of orally‐administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol. 2001;90(3):343–352.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Fujita T, Suzuki Y, et al. Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol. 2006;50(11):867–870.
   PubMed Web of Science ®Google Scholar
• Sakai F, Hosoya T, Ono-Ohmachi A, et al. Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PloS One. 2014;9(8):e105370.
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Moriya T, Sakai F, et al. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep. 2014;4:4638.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Fujitani N, Nakagawa H, et al. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci Rep. 2019;9(1):1–11.
   PubMedGoogle Scholar
• Hori T, Kiyoshima J, Shida K, et al. Effect of intranasal administration oflactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol. 2001;8(3):593–597.
   PubMedGoogle Scholar
• Vickers NJJCB. Animal communication: when i’m calling you, will you answer too? Curr Biol. 2017;27(14):R713–15.
   PubMed Web of Science ®Google Scholar
• Gabryszewski SJ, Bachar O, Dyer KD, et al. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol. 2011;186(2):1151–1161.
   PubMed Web of Science ®Google Scholar
• Villena J, Barbieri N, Salva S, et al. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat‐killed Lactobacillus casei. Microbiol Immunol. 2009;53(11):636–46.
   PubMed Web of Science ®Google Scholar
• Weiss G, Rasmussen S, Zeuthen LH, et al. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll‐like receptor‐2‐dependent mechanism. Immunology. 2010;131(2):268–81.
   PubMed Web of Science ®Google Scholar
• Khailova L, Petrie B, Baird CH, et al. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. PLoS One. 2014;9(5):e97861.
   PubMed Web of Science ®Google Scholar
• Iwabuchi N, Xiao J-Z, Yaeshima T, et al. Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice. Biol Pharm Bull. 2011;34(8):1352–1355.
   PubMed Web of Science ®Google Scholar
• Kawahara T, Takahashi T, Oishi K, et al. Consecutive oral administration of Bifidobacterium longum MM‐2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol Immunol. 2015;59(1):1–12.
   PubMed Web of Science ®Google Scholar
• Namba K, Hatano M, Yaeshima T, et al. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem. 2010;74(5):939–945.
   PubMed Web of Science ®Google Scholar
• Furuhashi K, Suda T, Hasegawa H, et al. Mouse lung CD103+ and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses. Am J Respir Cell Mol Biol. 2012;46(2):165–172.
   PubMedGoogle Scholar
• Gleeson M, Pyne DB. Respiratory inflammation and infections in high‐performance athletes. Immunol Cell Biol. 2016;94(2):124–131.
   PubMed Web of Science ®Google Scholar
• Van Puyenbroeck K, Hens N, Coenen S, et al. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr. 2012;95(5):1165–1171.
   PubMed Web of Science ®Google Scholar
• Sindhu KN, Sowmyanarayanan TV, Paul A, et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clinl Infect Dis. 2014;58(8):1107–1115.
   PubMed Web of Science ®Google Scholar
• Hirose Y, Murosaki, S, and Yamamoto, Y, et al. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J Nutr. 2006;136(12):3069–3073.
   PubMed Web of Science ®Google Scholar
• Maeda N, Nakamura, R, and Hirose, Y, et al. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol. 2009;9(9):1122–1125.
   PubMed Web of Science ®Google Scholar
• Izumo T, Maekawa, T, and Ida, M, et al. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol. 2010;10(9):1101–1106.
   PubMed Web of Science ®Google Scholar
• Fujimura KE, Demoor T, Rauch M, et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A. 2014;111(2):805–810.
   PubMed Web of Science ®Google Scholar
• Yasui H, Kiyoshima J, Hori T, et al. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol. 1999;6(2):186–192.
   PubMedGoogle Scholar
• Bandoro C, Runstadler JA, Lowen AC. Bacterial lipopolysaccharide destabilizes influenza viruses. MSphere. 2017;2(5):e00267–17.
   PubMed Web of Science ®Google Scholar
• Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10(6):350–356.
   PubMed Web of Science ®Google Scholar
• Bradley KC, Finsterbusch K, Schnepf D, et al. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep. 2019;28(1):245–256. e4.
   PubMed Web of Science ®Google Scholar
• Albenberg LG, Wu GDJG. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. 2014;146(6):1564–1572.
   PubMed Web of Science ®Google Scholar
• Varraso R, Chiuve SE, Fung TT, et al. Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study. BMJ. 2015;350:h286.
   PubMed Web of Science ®Google Scholar
• King DE, Egan BM, Woolson RF, et al. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007;167(5):502–506.
   PubMedGoogle Scholar
• Kazemian N, Kao D, Pakpour S. Fecal microbiota transplantation during and post-COVID-19 pandemic. Int J Mol Sci. 2021;22(6):3004.
   PubMed Web of Science ®Google Scholar
• Liu F, Ye S, Zhu X, et al. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021;15(1):1–9.
   PubMedGoogle Scholar
• Stewart CJ, Ajami NJ, O’Brien JL, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583–588.
   PubMed Web of Science ®Google Scholar
• Mutlu EA, Keshavarzian A, Losurdo J, et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 2014;10(2):e1003829.
   PubMed Web of Science ®Google Scholar
• Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52(6):910–941 .
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778.
   PubMed Web of Science ®Google Scholar
• Chhibber-Goel J, Gopinathan S, Sharma A. Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections? Gut Pathog. 2021;13(1):1–6.
   PubMed Web of Science ®Google Scholar
• Goncalves Mendes Neto A, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID‐19. J Med Virol. 2021;93(3):1489–1495.
   PubMed Web of Science ®Google Scholar
• Vila AV, Collij, V, and Sanna, S, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11(1):1–11.
   PubMed Web of Science ®Google Scholar